title: Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction.
abstract: OBJECTIVE
  The thyroid hormone system may be downregulated temporarily in patients who are severely ill. This "euthyroid sick syndrome" may be an adaptive response to conserve energy. However, thyroid hormone also has beneficial effects on the cardiovascular system, such as improving cardiac function, reducing systemic vascular resistance, and lowering serum cholesterol levels. We investigated whether thyroid hormone levels obtained at the time of myocardial infarction are associated with subsequent mortality.
  
  
  METHODS
  Serum levels of thyroid hormones (triiodothyronine [T3], reverse T3, free thyroxine [T4], and thyroid-stimulating hormone) were measured in 331 consecutive patients with acute myocardial infarction (mean age [+/- SD], 68 +/- 12 years), from samples obtained at the time of admission.
  
  
  RESULTS
  Fifty-three patients (16%) died within 1 year. Ten percent (16 of 165) of patients with reverse T3 levels (an inactive metabolite) >0.41 nmol/L (the median value) died within the first week after myocardial infarction, compared with none of the 166 patients with lower levels (P <0.0004). After 1 year, the corresponding figures were 24% (40 of 165) versus 7.8% (13 of 166; P <0.0001). Reverse T3 levels >0.41 nmol/L were associated with an increased risk of 1-year mortality (hazard ratio = 3.0; 95% confidence interval: 1.4 to 6.3; P = 0.005), independent of age, previous myocardial infarction, prior angina, heart failure, serum creatinine level, and peak serum creatine kinase-MB fraction levels.
  
  
  CONCLUSIONS
  Determination of reverse T3 levels may be a valuable and simple aid to improve identification of patients with myocardial infarction who are at high risk of subsequent mortality.
authors.affiliation: Department of Cardiology, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden.
authors.forename: L
authors.initials: L
authors.lastname: Friberg
authors.forename: V
authors.initials: V
authors.lastname: Drvota
authors.forename: A H
authors.initials: AH
authors.lastname: Bjelak
authors.forename: G
authors.initials: G
authors.lastname: Eggertsen
authors.forename: S
authors.initials: S
authors.lastname: Ahnve
mesh_terms: D000368:Aged; D015415:Biomarkers; D005260:Female; D006801:Humans; D008297:Male; D015999:Multivariate Analysis; D009203:Myocardial Infarction / Q000097:blood* / Q000401:mortality*; D011379:Prognosis; D016016:Proportional Hazards Models; D016019:Survival Analysis; D013548:Sweden / Q000453:epidemiology; D014285:Triiodothyronine, Reverse / Q000097:blood*
chemical_list: D015415:Biomarkers; D014285:Triiodothyronine, Reverse